Patents by Inventor Hyeong Eun Kim

Hyeong Eun Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230320991
    Abstract: Disclosed is a process for non-stop production of encapsulated probiotics, in which an alginate hydrogel is spontaneously formed through a simple process of culturing probiotics in a medium containing an alginate, a salt that forms a hydrogel by binding to alginic acid, preferably an insoluble carbonate, and optionally an encapsulation enhancer, and probiotics are encapsulated by the alginate hydrogel, thereby not only greatly improving the probiotic encapsulation process but also remarkably improving the freeze-drying viability, heat tolerance, shelf stability, and in-vivo stability (acid resistance and bile resistance) of probiotics.
    Type: Application
    Filed: June 10, 2023
    Publication date: October 12, 2023
    Inventors: Young-Hoo KIM, Hyeong-Eun KIM, Chi-Young HAN, Han Sol SEO, Tae-Yoon KIM, Sunghee LEE
  • Patent number: 11262365
    Abstract: The present invention relates to a kit for quantitative analysis of glycated hemoglobin (HbA1c), and the kit for quantitative analysis of HbA1c according to the present invention has excellent long-term stability of an enzyme reagent and thus has an effect of easily overcoming the disadvantages of the conventional reagents used in enzyme assays (e.g., storage, accuracy, portability, convenience of use, etc.).
    Type: Grant
    Filed: August 10, 2017
    Date of Patent: March 1, 2022
    Assignee: I-SENS, INC.
    Inventors: Dongxuan Shen, Jihoon Kim, Joo Young Cho, Kap Soo Park, Hyeong Eun Kim, Hyun Kyu Cho, Seok Won Lee, Hakhyun Nam, Geun Sig Cha
  • Publication number: 20190242910
    Abstract: The present invention relates to a kit for quantitative analysis of glycated hemoglobin (HbA1c), and the kit for quantitative analysis of HbA1c according to the present invention has excellent long-term stability of an enzyme reagent and thus has an effect of easily overcoming the disadvantages of the conventional reagents used in enzyme assays (e.g., storage, accuracy, portability, convenience of use, etc.).
    Type: Application
    Filed: August 10, 2017
    Publication date: August 8, 2019
    Inventors: Dongxuan Shen, Jihoon Kim, Joo Young Cho, Kap Soo Park, Hyeong Eun Kim, Hyun Kyu Cho, Seok Won Lee, Hakhyun Nam, Geun Sig Cha